Follow the Celon Pharma S.A. share price and the full directors' dealings record of the company, a publicly traded company based in Poland. Shares are listed on PL PL, under the authority of KNF. Operating in the Health Care sector, Celon Pharma S.A. has published 1 insider filings. Market capitalisation: €1.1bn. The latest transaction was reported on 18 May 2026 (Notification PDMR). Among the most active insiders: Anonymous (PDMR). The full history is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.